INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FL
Fu LuyangSr. VP, Chief Actuary - Sub
CINFCINCINNATI FINANCIAL CORP
Tax withholding
F$24K
147 sh
Apr 29, 2026May 1, 2026
Page 875 of 1737
← PrevNext →
traded Apr 29, 2026
+2d
SEC Form 4

Evidence

9
AD
Ackley DavidEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,284
131 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
MH
Martel William HEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,551
136 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
EA
Edwards Shirley AnnDirector
SOLVSolventum Corp
Option exercise
M—
3,403 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
CE
Ching Michael E.Director
PRIMPrimoris Services Corp
Grant or award
A—
268 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
RB
Raths BarbaraEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$5,010
104 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
RB
Raths BarbaraEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,284
131 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M—
155 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
MS
McKinney SamanthaDirector
CHRDChord Energy Corp
Grant or award
A—
1,524 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
PJ
Paulson JohnDirector
BLCOBausch & Lomb Corp
Grant or award
A$22K
1,375 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
AB
Albert BenjaminDirector, CEO
HCATHealth Catalyst, Inc.
Tax withholding
F$417
310 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
AB
Albert BenjaminDirector, CEO
HCATHealth Catalyst, Inc.
Grant or award
A—
1,124 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
RR
Rodriguez Jose RamonDirector
PRIMPrimoris Services Corp
Grant or award
A—
268 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
FA
Forbes AndrewEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$6,092
127 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
ME
Mily ElizabethDirector
SOLVSolventum Corp
Option exercise
M—
3,403 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
FA
Forbes AndrewEVP
CACCAMDEN NATIONAL CORP
Tax withholding
F$4,672
97 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
BJ
Baker JeffPrincipal Accounting Officer
CRWVCoreWeave, Inc.
Option exercise
M—
12.5K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

9
LL
Lawver Teri LDirector
ALTAltimmune, Inc.
Grant or award
A—
48.8K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

9
GP
Guerre Robert PaulSec, Dir of Corp Compliance
UFPIUFP INDUSTRIES INC
Grant or award
A$1,432
16 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

9
HK
Holth KristinDirector
NENoble Corp plc
Option exercise
M—
2,433 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

8
GJ
Gahlhoff Jerry Jr.Director, PRESIDENT & CEO
ROLROLLINS INC
Gift
G—
3,629 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

8
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$2.15M
78.3K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

8
WJ
Wassil JimCHIEF OPERATING OFFICER
PCVXVaxcyte, Inc.
Open-market sale · 10b5-1 plan
SELL$128K
2,250 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

7
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

7
SS
Sloan SheldonChief Medical Officer
SYRESpyre Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
78.3K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

6
BL
Burrows Scott LChief Financial Officer
SYRESpyre Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$181K
12.5K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

5
SR
Stangl RolfDirector
REYNReynolds Consumer Products Inc.
Grant or award
A—
10.7K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

5
FA
Flees Lori AnnDirector, President & CEO
VVVVALVOLINE INC
Grant or award
A$1,927
58 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

5
SP
Sharma PankajChief Business Officer
RELYRemitly Global, Inc.
Grant or award
A—
15.3K sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

5
KC
Karlsson Jutta CGeneral Counsel
ASAmer Sports, Inc.
Grant or award
A—
5,180 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

5
HA
Hardy AndrewEVP, Chief Sales Officer
NXPINXP Semiconductors N.V.
Option exercise
M—
4,880 sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

5
PE
Page Andrew EChief Financial Officer
ASAmer Sports, Inc.
Grant or award
A—
30.4K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

4
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Open-market sale · 10b5-1 plan
SELL$232K
3,079 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

4
AI
Aoki IchiroDirector, President
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
100.0K sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence

2
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
754 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

2
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
754 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

1
SA
Shafer AndrewChief Cust Mkt & Brnd Officer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
5,550 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

0
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Tax withholding · 10b5-1 plan
F$17K
230 sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC Form 4

Evidence

0
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
7,500 sh
Apr 29, 2026May 1, 2026
traded Apr 29, 2026
+2dSEC Form 4

Evidence

0
AI
Aoki IchiroDirector, President
INDIindie Semiconductor, Inc.
Option exercise · 10b5-1 plan
M—
100.0K sh
Apr 30, 2026May 1, 2026
traded Apr 30, 2026
+1dSEC Form 4

Evidence